Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Adc Therapeutics (ADCT)

Annual Return

Over the past 3 years, ADCT has had an average annual return of -3.54%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, ADCT has had an average annual return of -43.46%, underperforming the benchmark SPY, which returned +12.73% annual.

Since May 15, 2020, ADCT has had an average annual return of -39.87%, underperforming the benchmark SPY, which returned +18.46% annual.

2026202520242023202220212020
-63.90%+77.50%+19.82%-56.76%-80.99%-36.89%+7.96%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+2.27%+13.55%-8.53%+0.79%-10.04%-68.53%+19.11%-63.90%
2025-15.50%+4.76%-19.87%+1.26%+116.18%-13.24%+3.32%+10.81%+30.34%+11.49%-3.59%-17.86%+77.50%
2024+87.86%+54.85%-7.06%-1.78%-22.19%-7.87%+5.07%-12.68%+8.59%-10.45%-14.20%-17.77%+19.82%
2023+33.05%-29.54%-45.80%-0.61%+21.25%-8.58%-31.17%-18.84%-25.19%-22.11%+18.64%+100%-56.76%
2022-21.34%+5.09%-12.04%-19.86%-41.89%+16.21%-6.79%-7.96%-29.30%-7.93%-17.57%+4.94%-80.99%
2021-10.74%-6.93%-8.20%+0.53%-11.78%+12.46%-13.59%+38.64%-6.89%+6.74%-23.21%-9.26%-36.89%
2020+24.62%+26.69%-0.67%-5.01%-25.31%-13.03%+30.04%-14.20%+7.96%

Drawdown analysis of Adc Therapeutics (ADCT)

The maximum drawdown for the ADCT was -99.08%, occurring on Nov 9, 2023. This drawdown has not yet recovered.

The current ADCT drawdown is -97.50%.

Since May 15, 2020 ADCT has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.08%Jul 2, 2020845Nov 9, 2023OngoingOngoingOngoing
-7.90%May 28, 20206Jun 5, 20204Jun 11, 202010
-3.03%Jun 12, 20203Jun 17, 20202Jun 19, 20205
-1.20%Jun 23, 20202Jun 25, 20202Jun 29, 20204
-0.72%May 26, 20201May 27, 20201May 28, 20202